PT90212A - Processo aperfeicoado para a preparacao de derivados de 3-fenoloxi-3-fenil-propanaminas - Google Patents

Processo aperfeicoado para a preparacao de derivados de 3-fenoloxi-3-fenil-propanaminas

Info

Publication number
PT90212A
PT90212A PT90212A PT9021289A PT90212A PT 90212 A PT90212 A PT 90212A PT 90212 A PT90212 A PT 90212A PT 9021289 A PT9021289 A PT 9021289A PT 90212 A PT90212 A PT 90212A
Authority
PT
Portugal
Prior art keywords
propanamines
phenyl
phenoloxy
derivatives
preparation
Prior art date
Application number
PT90212A
Other languages
English (en)
Other versions
PT90212B (pt
Inventor
David Wayne Robertson
David Taiwai Wong
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PT90212A publication Critical patent/PT90212A/pt
Publication of PT90212B publication Critical patent/PT90212B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/23—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
    • C07C311/24—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/20—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT90212A 1988-04-08 1989-04-06 Processo aperfeicoado para a preparacao de derivados de 3-fenoloxi-3-fenil-propanaminas PT90212B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17936888A 1988-04-08 1988-04-08

Publications (2)

Publication Number Publication Date
PT90212A true PT90212A (pt) 1989-11-10
PT90212B PT90212B (pt) 1994-06-30

Family

ID=22656301

Family Applications (1)

Application Number Title Priority Date Filing Date
PT90212A PT90212B (pt) 1988-04-08 1989-04-06 Processo aperfeicoado para a preparacao de derivados de 3-fenoloxi-3-fenil-propanaminas

Country Status (19)

Country Link
EP (1) EP0336753B1 (pt)
JP (1) JPH0285236A (pt)
KR (1) KR890015995A (pt)
CN (1) CN1036562A (pt)
AT (1) ATE78029T1 (pt)
AU (1) AU611794B2 (pt)
CA (1) CA1337128C (pt)
DE (1) DE68901994T2 (pt)
DK (1) DK165489A (pt)
ES (1) ES2033525T3 (pt)
GR (1) GR3005662T3 (pt)
HU (1) HU205344B (pt)
IE (1) IE891122L (pt)
IL (1) IL89854A (pt)
NZ (1) NZ228636A (pt)
PH (1) PH27144A (pt)
PT (1) PT90212B (pt)
SU (1) SU1750421A3 (pt)
ZA (1) ZA892517B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK630987D0 (da) * 1987-12-01 1987-12-01 Ferrosan As Aryloxyphenylpropylaminer, deres fremstilling og anvendelse
FI912280A (fi) * 1990-05-17 1991-11-18 Lilly Co Eli Kiral syntes av 1-aryl-3-aminopropan-1 -oler.
US5281624A (en) * 1991-09-27 1994-01-25 Eli Lilly And Company N-alkyl-3-phenyl-3-(2-substituted phenoxy) propylamines and pharmaceutical use thereof
DK0537915T3 (da) * 1991-09-27 1995-11-27 Lilly Co Eli N-alkyl-3-phenyl-3-(2-alkylthiophenoxy)propylaminer som inhibitorer for epinephrin
EP0576766A1 (en) * 1992-06-29 1994-01-05 Novo Nordisk A/S Propanolamine derivatives, their preparation and use
IL110857A0 (en) * 1993-09-09 1994-11-28 Lilly Co Eli Cessation of tobacco use
US5936124A (en) * 1998-06-22 1999-08-10 Sepacor Inc. Fluoxetine process from benzoylpropionic acid
US6025517A (en) * 1998-08-03 2000-02-15 Sepracor Inc. Fluoxetine process from benzoylacetonitrile
ITMI20061987A1 (it) * 2006-10-16 2008-04-17 Archimica Srl Processo per la sintesi di arilossipropilammine ed eteroarilossipropilammine.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
DE2732750A1 (de) * 1977-07-20 1979-02-08 Merck Patent Gmbh Basische thioaether und verfahren zu ihrer herstellung
US4243681A (en) * 1977-10-11 1981-01-06 Mead Johnson & Company Alkylthiophenoxypropanolamines and pharmaceutical compositions and uses thereof
US4147805A (en) * 1978-07-28 1979-04-03 Mead Johnson & Company Alkylthiophenoxyalkylamines and the pharmaceutical use thereof
GB2060622B (en) * 1979-09-14 1983-05-25 Wyeth John & Brother Ltd 3-aryl-3-aryloxyalkylamines
US4569801A (en) * 1984-10-15 1986-02-11 Eli Lilly And Company Alkylsulfonamidophenylalkylamines

Also Published As

Publication number Publication date
HU205344B (en) 1992-04-28
HUT54976A (en) 1991-04-29
AU3252889A (en) 1989-10-12
IL89854A (en) 1994-02-27
DK165489A (da) 1989-10-09
CN1036562A (zh) 1989-10-25
IE891122L (en) 1989-10-08
EP0336753B1 (en) 1992-07-08
SU1750421A3 (ru) 1992-07-23
GR3005662T3 (pt) 1993-06-07
KR890015995A (ko) 1989-11-27
ATE78029T1 (de) 1992-07-15
ES2033525T3 (es) 1993-03-16
EP0336753A1 (en) 1989-10-11
CA1337128C (en) 1995-09-26
JPH0285236A (ja) 1990-03-26
NZ228636A (en) 1990-12-21
DK165489D0 (da) 1989-04-06
PT90212B (pt) 1994-06-30
ZA892517B (en) 1990-12-28
DE68901994D1 (de) 1992-08-13
PH27144A (en) 1993-04-02
DE68901994T2 (de) 1993-02-25
AU611794B2 (en) 1991-06-20

Similar Documents

Publication Publication Date Title
PT99261A (pt) Processo para a preparacao de herbicidas a base de aril-haloalquilpirazoles substituidos
NO904802L (no) Fremgangsmaate for fremstilling av aromatiske aminforbindelser.
BR8902297A (pt) Processo para a preparacao de 1,1,1,2-tetrafluoretano
BR8803759A (pt) Processo para a preparacao de 2,2,6,6-tetrametil-4-piperidilaminas
ES2138956T3 (es) Imidazoquinoxalinonas, sus analogos aza y procedimiento para su preparacion.
BR9003345A (pt) Processo para a preparacao de 1,1,1,2-tetrafluoretano
PT90569A (pt) Processo para a preparacao de 2-piperazinil- ou 2-homopiperazinil-1,2,3,4-tetra-hidronaftalenos
PT90212A (pt) Processo aperfeicoado para a preparacao de derivados de 3-fenoloxi-3-fenil-propanaminas
BR9200627A (pt) Processo para a preparacao de um composto e composto obtido
PT84459B (pt) Processo para a preparacao de derivados de ciclopropano 1,1-dissubstituidos
PT87946A (pt) Processo para a preparacao de derivados 4-amino susbtituido-1,2-dihidroxinaftaleno
FI895662A0 (fi) Menetelmä 3,4-difluorisubstituoidun benseenin valmistamiseksi
PT84750B (pt) Processo de preparacao de uma composicao para o envenenamento de roedores, a base de derivados de 1,4-naftoquinona
ES2089176T3 (es) Procedimiento para la preparacion de carboditioatos de piperidina fluorometil-sustituidos.
PT96088A (pt) Processo para a preparacao de compostos moluscicidas 2,4,5-tribomopirrole-3-carbonitrilo
PT95518A (pt) Processo para a preparacao de 3-aroil-2-oxindole-1-carboxamidas
BR9001870A (pt) Processo para a preparacao de 3-(organotio)aldeidos
PT89996A (pt) Processo para a preparacao de 3-(2,3,4,5,6-pentafluorofenoxi)-8-azabiciclo{3.2.1}octanos
PT84036B (pt) Processo para a preparacao de derivados de 1,5-benzotiazepina
PT96023A (pt) Processo para a preparacao de 3,4-epoxi-benzopiranos
BR8801947A (pt) Processo para a preparacao de 3-cloro-4,5-difluorobenzotrifluoreto
BR9200768A (pt) Processo para a preparacao de um composto e composto obtido
BR9004480A (pt) Processo para a preparacao de compostos aromaticos halogenio substituidos
FI102166B1 (fi) Menetelmä N,N-dimetyyliaminometyyliaryyliyhdisteiden valmistamiseksi
IT1230522B (it) Processo per la preparazione dicomposti mono-ossigenati da idrocarburi saturi.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19931206

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19950630